Skip to main content
Clinical Trials/ITMCTR2000003495
ITMCTR2000003495
Not yet recruiting
Phase 1

A clinical trial for the efficacy and safety of new Chinese herbal compound in reducing uric acid in patients

Tongren of Traditional Chinese Medicine0 sitesTBD
ConditionsHyperuricemia

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hyperuricemia
Sponsor
Tongren of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Tongren of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • Male and female aged 18 to 65 years; patients with a diagnosis of HUA \[sUA levels \>\=420 umol/L (7 mg/dL)in male and 360 umol/L in female]; Patients with gout and high uric acid.

Exclusion Criteria

  • Patients were excluded with HIV positive, hepatitis B or C infection, pregnant or lactating women, and active infection.

Outcomes

Primary Outcomes

Not specified

Similar Trials